Labshake search
Citations for R&D Systems :
451 - 500 of 10000+ citations for R 4 5 Isopropylidene 2 pentanoic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2023Quote: ... homogenized and digested in Cell Lysis Buffer #2 (R&D Systems) containing protease inhibitors on ice for 1 hour ...
-
bioRxiv - Developmental Biology 2023Quote: ... Goat anti-Runx 2 (1:100; R&D Systems AF2006-SP) and mouse anti-GM130 (1:100 ...
-
bioRxiv - Cancer Biology 2024Quote: ... type 2 (∼4mg/ml, Cultrex, RGF BME, Type2; R&D Systems) and maintained in LO complete media which consists of LO basic media -Advanced DMEM/F12 media (Thermo Fisher) ...
-
bioRxiv - Synthetic Biology 2024Quote: ... and 30 IU/mL recombinant human IL-2 (R&D Systems). Following isolation ...
-
bioRxiv - Systems Biology 2024Quote: ... Type 2 (BME; R&D Systems, Minneapolis, MN; 3533-001-02) and droplets of 60μL were plated onto 24-well plates ...
-
bioRxiv - Neuroscience 2024Quote: ... USA]) and growth factors (LM-22A4[2 mM, R&D Systems, Minneapolis ...
-
bioRxiv - Bioengineering 2024Quote: ... and 40 IU IL-2 (R&D Systems #202-IL-10). All cells were cultured at 37°C ...
-
bioRxiv - Immunology 2024Quote: ... or BME (Cultrex® RGF BME Type 2, R&D systems). GrowDex (supplied as a suspension of 1.5% nanofibrillar cellulose in 98.5% ultra-pure water ...
-
bioRxiv - Immunology 2021Quote: ... Mouse IL-2 DuoSet ELISA DuoSet and Ancillary Reagent Kit 2 were from R&D Systems.
-
bioRxiv - Bioengineering 2024Quote: ... 1 % P/S and 10 ng/ml fibroblast growth factor-2 (FGF-2, R&D Systems). Passage 3 hMSCs were used in this study.
-
bioRxiv - Cell Biology 2024Quote: ... 0.2mM ascorbic acid and 1 ng/mL recombinant human FGF (R&D system, 233-GMP-025). The adherent cells were split by trypsinization at 80% confluency and frozen at passage 2 (50% αMEM ...
-
bioRxiv - Cell Biology 2021Quote: ... Thy1+ Rep-MEFs were cultured in ‘iMPC medium’ containing 2 μg/mL of dox and administrated three small molecules: 5 μM of Forskolin (F) (R&D Systems, 1099/50), 5 μM of RepSox (R ...
-
bioRxiv - Bioengineering 2022Quote: ... and from Days 2 to 5 CHIR99021 was withdrawn and replaced with 100 ng/mL Activin A (R&D Systems, 338-AC-050/CF). Media change was performed every day by discarding spent media ...
-
bioRxiv - Cancer Biology 2021Quote: ... 3 µg/mL anti-ULBP2/5/6 (clone 165903, R&D Systems), and 6 µg/mL anti-ULBP3 (clone 166510 ...
-
bioRxiv - Cancer Biology 2021Quote: ... 5 ng/mL IL-12 (R&D Systems, cat#219-IL-005), 10 ng/mL IL-15 (NCI preclinical repository) ...
-
bioRxiv - Microbiology 2022Quote: ... and leptin DuoSet ELISA (1:5 dilution, R&D Systems, cat#DY406) were used to measure and confirm adiponectin and leptin levels ...
-
bioRxiv - Immunology 2022Quote: ... or NKG2D neutralizing antibody (5 µg/ml, R&D Systems, MAB139-100); ILC1-like cells demonstrated cytotoxic effect on HFs with 600 cells per well ...
-
bioRxiv - Immunology 2022Quote: ... or function-blocking NKG2D (5 µg/ml, R&D Systems, MAB139-100) antibodies ...
-
bioRxiv - Neuroscience 2024Quote: ... myogenic factor 5 (MYF5) (mouse monoclonal, MAB4027, R&D Systems, Minneapolis, USA), myosin heavy chain (MYHC ...
-
bioRxiv - Immunology 2024Quote: ... IL-5 and IL-13 were measured by ELISA (R&D systems). Results were normalized to cell number using CyQuant cell proliferation assay (Invitrogen ...
-
Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutationsbioRxiv - Genomics 2024Quote: ... or 5 µg of AREG neutralizing antibody (R&D Systems, MAB262-SP) or an equivalent volume of PBS ...
-
bioRxiv - Molecular Biology 2023Quote: ... 5 mM ATP) with 0.1 μM recombinant yeast E1 (R&D Systems), ...
-
bioRxiv - Developmental Biology 2023Quote: ... 5 ng/ml BMP7 (R&D Systems, cat# 354-BP-500/CF), and 50 ng/ml BMP12/GDF7 (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... plus 5 ng/mL of recombinant mouse IL-18 (R&D Systems). To retain intracellular mediators for downstream cytofluorimetric analyses ...
-
bioRxiv - Immunology 2023Quote: BMDMs were primed with murine IFNγ (5 ng/ml, R&D systems) for 16 h ...
-
bioRxiv - Molecular Biology 2023Quote: ... and 5 ng/ml human VEGF (R&D Systems Cat#. 293-VE). The 2-day-old EBs were dissociated and 6 × 104 cells were seeded onto individual wells of a 24-well plate coated with 0.1% gelatine in EC Induction Medium consisting of StemPro-34 medium (Gibco #10639011) ...
-
bioRxiv - Molecular Biology 2023Quote: ... After addition of 5 µl ISG15-AMC (R&D Systems #UL-553) substrate ...
-
bioRxiv - Bioengineering 2024Quote: ... rhTPO (5 ng ml−1, cat: 288-TPN-025, R&D Systems), rhFLT3L (5 ng ml−1 ...
-
bioRxiv - Bioengineering 2024Quote: ... rhFLT3L (5 ng ml−1, cat: 308-FK-025, R&D Systems), and rhSCF (50 ng ml−1 ...
-
bioRxiv - Cell Biology 2020Quote: ... and BMP4-Lif (10 ng/mL of mouse BMP-4 R&D Systems,Inc. ...
-
bioRxiv - Genomics 2020Quote: ... 4 μg normal rabbit IgG (R&D Systems, AB-105-C, lot: ER1212071) and ChIP-grade protein G magnetic beads (Cell Signalling 9006S ...
-
bioRxiv - Immunology 2022Quote: ... 30 μg/mL LPS plus 25 ng/mL IL-4 (R&D Systems); or 5 μg/mL LPS ...
-
bioRxiv - Cell Biology 2022Quote: ... and human bone morphogenetic protein 4 (hBMP4, 1.5 ng/ml; R&D Systems) together with human vascular endothelial growth factor (hVEGF ...
-
bioRxiv - Neuroscience 2022Quote: ... 25 µg/ml human recombinant Bone Morphogenetic Protein 4 (BMP4, R&D Systems) and 55 µM β-mercaptoethanol (Life technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Neuroscience 2020Quote: ... Antibodies used to assess pluripotency were anti-OCT3/4 (R&D Systems AF1759), anti-SOX2 (BD 245619) ...
-
bioRxiv - Bioengineering 2024Quote: ... 1 ng/mL human bone morphogenetic protein 4 (Bmp4) (R&D Systems, Inc.), 20 ng/mL human basic fibroblast growth factor (b-FGF ...
-
bioRxiv - Cell Biology 2024Quote: ... 15 ng/mL BMP-4 (314-BP-050/CF; R&D Systems Inc) and 125 ng/mL Fibroblast growth factor (FGF ...
-
bioRxiv - Bioengineering 2023Quote: ... at 4°C for 16 h and measured via ELISA (R&D Systems). The distribution of TGF-β in Ø2×2 mm and Ø5×2 mm constructs was predicted via FE model (FEBio ...
-
bioRxiv - Immunology 2022Quote: ... or 4 μg/mL of anti-CCL1 Ab (clone 148113; R&D Systems), was added to the cultures.
-
bioRxiv - Immunology 2022Quote: ... 4 μg/mL of anti-CCL5 Ab (polyclonal goat IgG; R&D Systems), or 4 μg/mL of anti-CCL1 Ab (clone 148113 ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were cultured for 4 days with 3 μM CHIR (R&D Systems); 3 days with 200 ng/mL FGF9 (R&D Systems) ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/mL of IL-4 (R&D systems, 402-ML-020)) ...
-
bioRxiv - Bioengineering 2023Quote: ... or 4 µg mL-1 human PDGFR beta antibody (AF385, R&D Systems) and 10 µg mL-1 human/mouse/rat alpha-smooth muscle actin antibody (MAB1420 ...
-
bioRxiv - Immunology 2023Quote: ... with 50 ng/ml of IL-4 (R&D systems, Minneapolis, MN, USA) and 50 ng/ml of GM-CSF (R&D Systems ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Cell Biology 2024Quote: ... Noggin 50ng/ml (day 0-4, 1967-NG-025/CF, R&D systems), DKK-1 10 ng/ml (day 0-6 ...
-
bioRxiv - Developmental Biology 2024Quote: ... 50 ng/mL bone morphogenic protein 4 (hBMP4, R&D Systems #314-BP), 10 ng/mL granulocyte colony-stimulating factor (hG-CSF ...
-
bioRxiv - Cell Biology 2022Quote: ... Experiments were done in 293T cells pretreated with 5 ng/ml recombinant human R-spondin 3 (R&D Systems, Minneapolis, USA). Experiments were performed with biological triplicates ...
-
bioRxiv - Cell Biology 2020Quote: ... IL-2 concentration was measured using a human IL-2 ELISA kit (R&D Systems, DY202-05) following the manufacturer’s instructions.